QuantLogix's 5-factor engine currently reads Regeneron Pharmaceuticals Inc (REGN) as a buy at 60/100 — a bullish setup. Options is the strongest leg at 77/100, while microstructure lags at 53/100. In backtesting, 54% of 50 comparable historical setups moved higher within five trading days. REGN trades in the Pharmaceutical Preparations sector with a $86.6B market cap.
Live 5-factor quant signal — technical, momentum, fundamental, options, and microstructure — recomputed every few minutes. Educational market analysis, not investment advice. QuantLogix does not provide personalized recommendations. See the verified track record → · Browse all signal scorecards →